Equities research analysts at Buckingham Research assumed coverage on shares of Livent (NASDAQ:LTHM) in a research report issued to clients and investors on Wednesday, November 14th, Marketbeat.com reports. The brokerage set a “neutral” rating and a $18.00 price target on the stock. Buckingham Research’s price target would suggest a potential upside of 7.14% from the stock’s current price. The analysts noted that the move was a valuation call.

A number of other brokerages have also recently issued reports on LTHM. Loop Capital began coverage on Livent in a research report on Friday, November 9th. They issued a “buy” rating and a $22.00 target price for the company. Credit Suisse Group began coverage on Livent in a research report on Monday, November 5th. They issued an “outperform” rating and a $20.00 target price for the company. Nomura started coverage on Livent in a research report on Monday, November 5th. They issued a “buy” rating and a $20.00 target price for the company. Citigroup started coverage on Livent in a research note on Monday, November 5th. They set a “buy” rating and a $20.00 price objective for the company. Finally, Bank of America started coverage on Livent in a research note on Monday, November 5th. They set a “buy” rating and a $20.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $20.20.

Shares of NASDAQ:LTHM traded down $0.46 on Wednesday, hitting $16.80. 943,242 shares of the company’s stock were exchanged, compared to its average volume of 1,393,328. Livent has a 1-year low of $14.00 and a 1-year high of $19.90.

Livent (NASDAQ:LTHM) last released its quarterly earnings data on Tuesday, November 6th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.21 by $0.04. The business had revenue of $112.00 million for the quarter, compared to analyst estimates of $113.40 million.

About Livent

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.

Further Reading: What is a capital gain?

Analyst Recommendations for Livent (NASDAQ:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.